• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2003-2007 年苏格兰诊断为乳腺癌或结直肠癌后 30 天内死亡患者的特征。

Characteristics of patients dying within 30 days of diagnosis of breast or colorectal cancer in Scotland, 2003-2007.

机构信息

Information Services Division, NHS National Services Scotland, Gyle Square, 1 South Gyle Crescent, Edinburgh EH12 9EB, UK.

出版信息

Br J Cancer. 2011 Jan 4;104(1):60-7. doi: 10.1038/sj.bjc.6606036.

DOI:10.1038/sj.bjc.6606036
PMID:21206498
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3039825/
Abstract

BACKGROUND

Recent research has shown that most of the excess risk of death following breast and colorectal cancer in England compared with Norway and Sweden occurs in older age groups during the first year, and especially in the first month of follow-up. The aim of this study was to explore the characteristics of patients dying within 30 days of being diagnosed with one of these cancers in Scotland during 2003-2007.

METHODS

Anonymised cancer registry records linked to hospital discharge and death records were extracted. The study population was divided into patients who died within 30 days of diagnosis (cases) and those who survived beyond this threshold (controls). Differences in patient-, tumour-, and health service-related characteristics were assessed using the χ(2)-test and logistic regression.

RESULTS

Patients dying within 30 days were more likely to be elderly and to have experienced emergency admission to non-surgical specialities. Their tumours were less likely to have been verified microscopically, but they appeared more likely to be of high grade and advanced in stage. A substantial number of patients died from causes other than their cancer.

CONCLUSION

These results suggest that early mortality after a diagnosis of breast or colorectal cancer may be partly due to comorbidity and lifestyle factors, as well as due to more advanced disease. Further research is required to determine the precise explanation for these findings and, in particular, if any potentially avoidable factors such as delays in presentation, referral, or diagnosis exist.

摘要

背景

最近的研究表明,与挪威和瑞典相比,英格兰乳腺癌和结直肠癌患者的死亡风险在随访的第一年,尤其是在第一个月,会在老年人群中显著增加。本研究旨在探索 2003 年至 2007 年期间苏格兰诊断出此类癌症后 30 天内死亡的患者的特征。

方法

提取匿名癌症登记处记录,并与医院出院和死亡记录相关联。研究人群分为在诊断后 30 天内死亡的患者(病例)和超过该时间阈值存活的患者(对照组)。使用 χ(2)-检验和逻辑回归评估患者、肿瘤和卫生服务相关特征的差异。

结果

在 30 天内死亡的患者更可能是老年人,并且更有可能经历非外科专业的紧急入院。他们的肿瘤更不可能经过显微镜验证,但似乎更有可能是高级别和晚期的。相当数量的患者死于癌症以外的其他原因。

结论

这些结果表明,乳腺癌或结直肠癌诊断后的早期死亡率可能部分归因于合并症和生活方式因素,以及更晚期的疾病。需要进一步研究以确定这些发现的确切解释,特别是是否存在任何潜在可避免的因素,如就诊、转诊或诊断延迟。

相似文献

1
Characteristics of patients dying within 30 days of diagnosis of breast or colorectal cancer in Scotland, 2003-2007.2003-2007 年苏格兰诊断为乳腺癌或结直肠癌后 30 天内死亡患者的特征。
Br J Cancer. 2011 Jan 4;104(1):60-7. doi: 10.1038/sj.bjc.6606036.
2
Aspects of survival from colorectal cancer in Denmark.丹麦结直肠癌的生存情况
Dan Med J. 2012 Apr;59(4):B4428.
3
Cohort profile: the MCC-Spain follow-up on colorectal, breast and prostate cancers: study design and initial results.队列研究概况:西班牙结直肠癌、乳腺癌和前列腺癌的 MCC 随访:研究设计和初步结果。
BMJ Open. 2019 Nov 21;9(11):e031904. doi: 10.1136/bmjopen-2019-031904.
4
Outcomes for patients who develop both breast and colorectal cancer.同时患有乳腺癌和结直肠癌患者的结局。
Ann Surg Oncol. 2012 Jan;19(1):242-8. doi: 10.1245/s10434-011-1843-8. Epub 2011 Jun 24.
5
A population-based comparison of the survival of patients with colorectal cancer in England, Norway and Sweden between 1996 and 2004.1996 年至 2004 年期间,英格兰、挪威和瑞典的基于人群的结直肠癌患者生存情况比较。
Gut. 2011 Aug;60(8):1087-93. doi: 10.1136/gut.2010.229575. Epub 2011 Feb 8.
6
Potentially inappropriate medication use in older patients with breast and colorectal cancer.老年乳腺癌和结直肠癌患者潜在不适当药物使用。
Cancer. 2018 Jul 15;124(14):3000-3007. doi: 10.1002/cncr.31403. Epub 2018 Apr 24.
7
Breast cancer diagnosis and mortality by tumor stage and migration background in a nationwide cohort study in Sweden.瑞典一项全国性队列研究中按肿瘤分期和移民背景划分的乳腺癌诊断与死亡率
Breast. 2017 Feb;31:57-65. doi: 10.1016/j.breast.2016.10.004. Epub 2016 Nov 2.
8
Effect of longer health service provider delays on stage at diagnosis and mortality in symptomatic breast cancer.医疗服务提供者较长时间的延误对有症状乳腺癌诊断分期及死亡率的影响。
Breast. 2015 Jun;24(3):248-55. doi: 10.1016/j.breast.2015.02.027. Epub 2015 Mar 7.
9
Stage at diagnosis and early mortality from cancer in England.英格兰癌症诊断阶段及早期死亡率。
Br J Cancer. 2015 Mar 31;112 Suppl 1(Suppl 1):S108-15. doi: 10.1038/bjc.2015.49.
10
Italian cancer figures--Report 2015: The burden of rare cancers in Italy.意大利癌症数据——2015年报告:意大利罕见癌症的负担
Epidemiol Prev. 2016 Jan-Feb;40(1 Suppl 2):1-120. doi: 10.19191/EP16.1S2.P001.035.

引用本文的文献

1
Health inequalities in cancer care: a literature review of pathways to diagnosis in the United Kingdom.癌症护理中的健康不平等:英国癌症诊断途径的文献综述
EClinicalMedicine. 2024 Sep 27;76:102864. doi: 10.1016/j.eclinm.2024.102864. eCollection 2024 Oct.
2
Prognostic determinants in cancer survival: a multidimensional evaluation of clinical and genetic factors across 10 cancer types in the participants of Genomics England's 100,000 Genomes Project.癌症生存的预后决定因素:对英国基因组学10万基因组计划参与者中10种癌症类型的临床和遗传因素进行多维度评估
Discov Oncol. 2024 Sep 15;15(1):448. doi: 10.1007/s12672-024-01310-8.
3
Early death after a diagnosis of metastatic solid cancer-raising awareness and identifying risk factors from the SEER database.转移性实体瘤诊断后的早期死亡——从 SEER 数据库中提高认识和识别风险因素。
PLoS One. 2023 Sep 26;18(9):e0281561. doi: 10.1371/journal.pone.0281561. eCollection 2023.
4
Predictors of an early death in patients diagnosed with colon cancer: a retrospective case-control study in the UK.诊断为结肠癌的患者早期死亡的预测因素:英国回顾性病例对照研究。
BMJ Open. 2019 Jun 19;9(6):e026057. doi: 10.1136/bmjopen-2018-026057.
5
Treatment Patterns Among De Novo Metastatic Cancer Patients Who Died Within 1 Month of Diagnosis.诊断后1个月内死亡的初发性转移性癌症患者的治疗模式
JNCI Cancer Spectr. 2019 Jun;3(2):pkz021. doi: 10.1093/jncics/pkz021. Epub 2019 Apr 15.
6
Emergency presentation of colorectal patients in Spain.西班牙结直肠病患者的急诊表现。
PLoS One. 2018 Oct 1;13(10):e0203556. doi: 10.1371/journal.pone.0203556. eCollection 2018.
7
Indicators for early assessment of palliative care in lung cancer patients: a population study using linked health data.用于评估肺癌患者姑息治疗早期效果的指标:基于健康数据关联的人群研究。
BMC Palliat Care. 2018 Feb 26;17(1):37. doi: 10.1186/s12904-018-0285-5.
8
Investigation of the international comparability of population-based routine hospital data set derived comorbidity scores for patients with lung cancer.基于人群的常规医院数据集衍生的肺癌患者合并症评分的国际可比性研究。
Thorax. 2018 Apr;73(4):339-349. doi: 10.1136/thoraxjnl-2017-210362. Epub 2017 Oct 27.
9
Does emergency presentation of cancer represent poor performance in primary care? Insights from a novel analysis of linked primary and secondary care data.癌症急诊就诊是否意味着初级医疗服务表现不佳?来自对初级和二级医疗服务关联数据的全新分析的见解。
Br J Cancer. 2017 Apr 25;116(9):1148-1158. doi: 10.1038/bjc.2017.71. Epub 2017 Mar 23.
10
Risk factors for emergency presentation with lung and colorectal cancers: a systematic review.肺癌和结直肠癌急诊就诊的危险因素:一项系统评价。
BMJ Open. 2015 Apr 2;5(4):e006965. doi: 10.1136/bmjopen-2014-006965.

本文引用的文献

1
New trends in health inequalities research: now it's personal.健康不平等研究的新趋势:现在关注个体层面。
Lancet. 2010 Sep 11;376(9744):854-5. doi: 10.1016/S0140-6736(10)60313-3. Epub 2010 Jul 19.
2
National comparisons of lung cancer survival in England, Norway and Sweden 2001-2004: differences occur early in follow-up.2001-2004 年英格兰、挪威和瑞典的肺癌生存率的国家比较:随访早期就出现差异。
Thorax. 2010 May;65(5):436-41. doi: 10.1136/thx.2009.124222.
3
Breast cancer survival in England, Norway and Sweden: a population-based comparison.英格兰、挪威和瑞典的乳腺癌生存情况:一项基于人群的比较。
Int J Cancer. 2010 Dec 1;127(11):2630-8. doi: 10.1002/ijc.25264.
4
Risk factors for delayed presentation and referral of symptomatic cancer: evidence for common cancers.症状性癌症延迟就诊和转诊的风险因素:常见癌症的证据。
Br J Cancer. 2009 Dec 3;101 Suppl 2(Suppl 2):S92-S101. doi: 10.1038/sj.bjc.6605398.
5
Do diagnostic delays in cancer matter?癌症的诊断延迟有关系吗?
Br J Cancer. 2009 Dec 3;101 Suppl 2(Suppl 2):S9-S12. doi: 10.1038/sj.bjc.6605384.
6
Interventions to promote cancer awareness and early presentation: systematic review.促进癌症意识和早期就诊的干预措施:系统评价。
Br J Cancer. 2009 Dec 3;101 Suppl 2(Suppl 2):S31-9. doi: 10.1038/sj.bjc.6605388.
7
Public awareness of cancer in Britain: a population-based survey of adults.英国民众对癌症的认知:一项针对成年人的基于人群的调查。
Br J Cancer. 2009 Dec 3;101 Suppl 2(Suppl 2):S18-23. doi: 10.1038/sj.bjc.6605386.
8
Cancer survival in England and the influence of early diagnosis: what can we learn from recent EUROCARE results?英格兰的癌症存活率及早期诊断的影响:我们能从最近的 EUROCARE 研究结果中学到什么?
Br J Cancer. 2009 Dec 3;101 Suppl 2(Suppl 2):S102-9. doi: 10.1038/sj.bjc.6605399.
9
Health behaviors influence cancer survival.健康行为会影响癌症生存率。
J Clin Oncol. 2009 Apr 20;27(12):1930-2. doi: 10.1200/JCO.2008.21.3769. Epub 2009 Mar 16.
10
Smoking and alcohol intervention before surgery: evidence for best practice.术前吸烟与酒精干预:最佳实践证据
Br J Anaesth. 2009 Mar;102(3):297-306. doi: 10.1093/bja/aen401.